Ibrutinib
Study Identifies Cardiovascular Toxicities Associated With Ibrutinib
The study identified several cardiovascular toxicities associated with ibrutinib, including supraventricular ...
SEPTEMBER 27, 2019
Ibrutinib Bests Drug Combo in Older CLL Pts
In older patients with newly diagnosed chronic lymphocytic leukemia (CLL), ibrutinib provided a significant ...
MARCH 11, 2019
FDA Approves Imbruvica With Gazyva for First-Line CLL Treatment
The FDA expanded the labeling for Imbruvicato include use with Gazyva in treatment-naive patients with chronic ...
FEBRUARY 4, 2019
Imbruvica Approved to Treat Waldenström Macroglobulinemia With Rituxan
The FDA approved the use of ibrutinib (Imbruvica, Pharmacyclics/Janssen) in combination with rituximab ...
AUGUST 30, 2018
Load more